## Background: The primary diagnosis of non-hodgkin's lymphoma/leukemia (nhl) by fine-needle aspiration (fna) is controversial. the authors reviewed their experience with fna and flow cytometry (fc) to determine the usefulness and limitations of these techniques in the diagnosis of nhl. ## Methods
Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-hodgkin lymphoma
β Scribed by Zeppa, Pio ;Marino, Gilda ;Troncone, Giancarlo ;Fulciniti, Franco ;De Renzo, Amalia ;Picardi, Marco ;Benincasa, Giulio ;Rotoli, Bruno ;Vetrani, Antonio ;Palombini, Lucio
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 350 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND.
Flow cytometry (FC) is a useful adjunct to fine-needle aspiration cytology (FNC) in evaluating lymphoproliferative disorders. The authors present a critical review of 307 lymph nodal and extra lymph nodal lymphoproliferative disorders that were diagnosed with FNC and FC.
METHODS. FC was
performed over a 4-year period on 185 palpable and 122 impalpable lymph nodal and extra lymph nodal lymphoproliferative processes under ultrasound or computed tomography guidance. FC was performed using the following fluoresceinated antibodies: CD3, CD4/CD8, CD2/CD7/CD3, CD5/CD10/ CD19, CD19//, FMC7/CD23/CD19, CD38/CD56/CD19, and bcl-2. The series included 15 inadequate, 10 suspicious, and 135 benign reactive hyperplasias (BRHs); 70 primary non-Hodgkin lymphomas (NHLs), and 77 recurrent NHLs (rNHLs). FC/FNC diagnoses of suspicious, NHL, and rNHL were controlled either histologically or clinically or by the interphase fluorescence in situ hybridization demonstration of t(11;14)(q13;q32) in two cases of mantle cell lymphoma. BRHs were controlled by follow-up. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the FC/FNC diagnoses of NHL, rNHL, and BRH were calculated as well as the identification of specific subtypes among the small-and medium-sized cells.
RESULTS.
Statistical analysis showed 93% sensitivity, 100% specificity, 100% PPV, and 91% NPV in NHL, rNHL, and BRH discrimination. The subclassification of small cell and medium-sized NHLs showed 63% sensitivity, 88% specificity, 95% PPV, and 37% NPV.
CONCLUSIONS. FC applied to FNC enhanced the precision of cytologic diagnosis in
lymph nodal and extra lymph nodal lymphoproliferative disorders and allowed further subclassification in more than half of the cases, thus avoiding invasive surgical biopsies in many patients. Cancer (Cancer Cytopathol) 2004;102:55-65.
π SIMILAR VOLUMES
In this prospective study, we correlated cytological grading and clinical follow-up of non-Hodgkin's lymphomas (NHL) with DNA flow cytometry (FCM) data from fine-needle aspiration biopsy (FNAB) material. FNAB was performed from 34 successive cases of NHL, and the aspirated material was analyzed by D
## Abstract The Revised European American lymphoma (REAL) and World Health Organization (WHO) classification of nonβHodgkin's lymphoma (NHL) relies on the constellation of cytologic, phenotypic, genotypic, and clinical characteristics of NHL. For the most part, the classification does not rely on a
## INTRODUCTION. Although the cytologic features of Hodgkin disease (HD) has been well described, HD accounts for most of the false-negative fine-needle aspiration (FNA) biopsies of malignant lymphomas. In this study, the authors examined the factors contributing to a false-negative diagnosis of H